FRISON, LUCA

FRISON, LUCA  

Mostra records
Risultati 1 - 4 di 4 (tempo di esecuzione: 0.005 secondi).
Titolo Data di pubblicazione Autore(i) File
Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients. 1-gen-2015 Tiribelli, M; Bonifacio, Massimiliano; Binotto, G; Maino, E; Calistri, E; De Marchi, F; Scaffidi, Luigi; Frison, Luca; Medeot, M; Ambrosetti, Achille; Semenzato, G; Fanin, R.
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response 1-gen-2015 Bonifacio, Massimiliano; Binotto, G; Maino, E; Calistri, E; Marin, L; Scaffidi, Luigi; Frison, Luca; De Marchi, F; Krampera, Mauro; Semenzato, G; Fanin, R; Ambrosetti, Achille; Tiribelli, M.
Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC. 1-gen-2015 Bonifacio, Massimiliano; Scaffidi, Luigi; Binotto, G; De Marchi, F; Maino, E; Calistri, E; Bonalumi, Angela; Frison, Luca; Marin, L; Medeot, M; DE MATTEIS, Giovanna; Fanin, R; Semenzato, G; Ambrosetti, Achille; Tiribelli, M.
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 1-gen-2016 Bonifacio, Massimiliano; Binotto, G.; Tiribelli, M.; Scaffidi, Luigi; Iurlo, A.; Cibien, F.; Maino, E.; Guella, A.; Festini, G.; Minotto, C.; De Biasi, E.; Frison, Luca; De Marchi, F.; Medeot, M.; Bucelli, C.; Calistri, E.; Stulle, M.; Gherlinzoni, F.; Cortelezzi, A.; Fanin, R.; Semenzato, Giampietro; Krampera, Mauro; Pizzolo, Giovanni; Ambrosetti, Achille